Current and Future Applications of Circulating Tumor DNA in CRC: biomarker testing, minimal residual disease, and screening

Includes a Live Event on 10/26/2021 at 6:00 PM (CDT)

Kristin Price, MS presents "Current and Future Applications of Circulating Tumor DNA in CRC: biomarker testing, minimal residual disease, and screening" on behalf of SGNA.

This webinar will review the current and future applications of ctDNA for colorectal cancer from screening to testing for minimal residual disease in early stage cancers and biomarker testing in advanced stage cancer. 

Continuing education: The Society of Gastroenterology Nurses and Associates, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation

Contact hour(s): 1.00

Contact hour(s) recording expiration: October 26, 2024

According to the American Board of Certification for Gastroenterology Nurses (ABCGN), 1.00 hour earned in this activity is considered approved (GI Specific).  According to the criteria of the International Association of Healthcare Central Service Materiel Management (IAHCSMM), 1.00 CE earned in this activity is considered approved.

Successful completion:

1. View entire webinar

2. Complete online evaluation. 

SGNA is provider-approved by the California Board of Registered Nursing, Provider Number CEP 11579. Check with your state board of nursing for acceptability of education sessions for re-licensure.


Key:

Complete
Failed
Available
Locked
Current and Future Applications of Circulating Tumor DNA in CRC: biomarker testing, minimal residual disease, and screening
10/26/2021 at 6:00 PM (CDT)   |  60 minutes
10/26/2021 at 6:00 PM (CDT)   |  60 minutes
Webinar Evaluation
8 Questions
Certificate
1.00 CH credit  |  Certificate available
1.00 CH credit  |  Certificate available